Loading…
Arylamines QSAR-Based Design and Molecular Dynamics of New Phenylthiophene and Benzimidazole Derivatives with Affinity for the C111, Y268, and H73 Sites of SARS-CoV-2 PLpro Enzyme
A non-structural SARS-CoV-2 protein, PLpro, is involved in post-translational modifications in cells, allowing the evasion of antiviral immune response mechanisms. In this study, potential PLpro inhibitory drugs were designed using QSAR, molecular docking, and molecular dynamics. A combined QSAR equ...
Saved in:
Published in: | Pharmaceuticals (Basel, Switzerland) Switzerland), 2024-05, Vol.17 (5), p.606 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c484t-7ce0b3869c18a94c5d077f82b3b359cfdd22cc1f0b4d047478ef8e2680f396813 |
---|---|
cites | cdi_FETCH-LOGICAL-c484t-7ce0b3869c18a94c5d077f82b3b359cfdd22cc1f0b4d047478ef8e2680f396813 |
container_end_page | |
container_issue | 5 |
container_start_page | 606 |
container_title | Pharmaceuticals (Basel, Switzerland) |
container_volume | 17 |
creator | Sabadini, Gianfranco Mellado, Marco Morales, César Mella, Jaime |
description | A non-structural SARS-CoV-2 protein, PLpro, is involved in post-translational modifications in cells, allowing the evasion of antiviral immune response mechanisms. In this study, potential PLpro inhibitory drugs were designed using QSAR, molecular docking, and molecular dynamics. A combined QSAR equation with physicochemical and Free-Wilson descriptors was formulated. The r
, q
, and r
values were 0.833, 0.770, and 0.721, respectively. From the equation, it was found that the presence of an aromatic ring and a basic nitrogen atom is crucial for obtaining good antiviral activity. Then, a series of structures for the binding sites of C111, Y268, and H73 of PLpro were created. The best compounds were found to exhibit pIC
values of 9.124 and docking scoring values of -14 kcal/mol. The stability of the compounds in the cavities was confirmed by molecular dynamics studies. A high number of stable contacts and good interactions over time were exhibited by the aryl-thiophenes Pred14 and Pred15, making them potential antiviral candidates. |
doi_str_mv | 10.3390/ph17050606 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_96613e1ff62348889017a07c566edf24</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A795450133</galeid><doaj_id>oai_doaj_org_article_96613e1ff62348889017a07c566edf24</doaj_id><sourcerecordid>A795450133</sourcerecordid><originalsourceid>FETCH-LOGICAL-c484t-7ce0b3869c18a94c5d077f82b3b359cfdd22cc1f0b4d047478ef8e2680f396813</originalsourceid><addsrcrecordid>eNptks9uEzEQxlcIREvhwgMgS1wQ6hZ77bW9xzT9KwUoBJA4rRzvOHG0awd702rzWrwgblJaQMgHj0a_75sZzWTZS4KPKK3wu9WCCFxijvmjbJ-wguWyYOLxH_Fe9izGJcalIIw8zfaoFBUjQuxnP0dhaFVnHUT0aTr6nB-rCA06gWjnDinXoPe-Bb1uVUAng0ukjsgb9AFu0NUC3ND2C-tXKYItfQxuYzvbqE2SJZtgr1Vvr5P7je0XaGSMdbYfkPEB9QtAY0LIIfpecHm41V8Iiqa2h22R1M80H_tveYGuJqvg0anbDB08z54Y1UZ4cfcfZF_PTr-ML_LJx_PL8WiSayZZnwsNeEYlrzSRqmK6bLAQRhYzOqNlpU3TFIXWxOAZazATTEgwElIn2NCKS0IPssudb-PVsl4F26kw1F7ZepvwYV6r0FvdQl1xTigQY3hBmZSywkQoLHTJOTSmYMnrzc4rjfFjDbGvOxs1tK1y4Nexpml9VJKC8IS-_gdd-nVwadJElRUvGeHlAzVXqb51xvdB6VvTeiSqkpWYUJqoo_9Q6TWQNukdGJvyfwne7gQ6-BgDmPu5Ca5vr61-uLYEv7rrdD3roLlHf58X_QWuN8o9</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3059654165</pqid></control><display><type>article</type><title>Arylamines QSAR-Based Design and Molecular Dynamics of New Phenylthiophene and Benzimidazole Derivatives with Affinity for the C111, Y268, and H73 Sites of SARS-CoV-2 PLpro Enzyme</title><source>PubMed Central(OA)</source><source>ProQuest - Publicly Available Content Database</source><source>Coronavirus Research Database</source><creator>Sabadini, Gianfranco ; Mellado, Marco ; Morales, César ; Mella, Jaime</creator><creatorcontrib>Sabadini, Gianfranco ; Mellado, Marco ; Morales, César ; Mella, Jaime</creatorcontrib><description>A non-structural SARS-CoV-2 protein, PLpro, is involved in post-translational modifications in cells, allowing the evasion of antiviral immune response mechanisms. In this study, potential PLpro inhibitory drugs were designed using QSAR, molecular docking, and molecular dynamics. A combined QSAR equation with physicochemical and Free-Wilson descriptors was formulated. The r
, q
, and r
values were 0.833, 0.770, and 0.721, respectively. From the equation, it was found that the presence of an aromatic ring and a basic nitrogen atom is crucial for obtaining good antiviral activity. Then, a series of structures for the binding sites of C111, Y268, and H73 of PLpro were created. The best compounds were found to exhibit pIC
values of 9.124 and docking scoring values of -14 kcal/mol. The stability of the compounds in the cavities was confirmed by molecular dynamics studies. A high number of stable contacts and good interactions over time were exhibited by the aryl-thiophenes Pred14 and Pred15, making them potential antiviral candidates.</description><identifier>ISSN: 1424-8247</identifier><identifier>EISSN: 1424-8247</identifier><identifier>DOI: 10.3390/ph17050606</identifier><identifier>PMID: 38794177</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Amino acids ; Analysis ; Antiviral agents ; Antiviral drugs ; Atazanavir ; Benzimidazoles ; Chemical properties ; coronavirus ; Coronaviruses ; COVID-19 ; Drugs ; Enzyme kinetics ; Enzymes ; Etravirine ; Free-Wilson ; Health aspects ; Hydrogen bonds ; Molecular dynamics ; Mortality ; Mutation ; PLpro ; Proteins ; QSAR ; RNA ; RNA polymerase ; SARS-CoV-2 ; Severe acute respiratory syndrome coronavirus 2 ; Structure ; Structure-activity relationship (Pharmacology) ; Structure-activity relationships ; Testing ; Thiophene ; Vaccines</subject><ispartof>Pharmaceuticals (Basel, Switzerland), 2024-05, Vol.17 (5), p.606</ispartof><rights>COPYRIGHT 2024 MDPI AG</rights><rights>2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c484t-7ce0b3869c18a94c5d077f82b3b359cfdd22cc1f0b4d047478ef8e2680f396813</citedby><cites>FETCH-LOGICAL-c484t-7ce0b3869c18a94c5d077f82b3b359cfdd22cc1f0b4d047478ef8e2680f396813</cites><orcidid>0000-0002-2434-8461 ; 0000-0001-9577-5180 ; 0009-0009-1925-3167</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3059654165/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3059654165?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25753,27924,27925,37012,37013,38516,43895,44590,74412,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38794177$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sabadini, Gianfranco</creatorcontrib><creatorcontrib>Mellado, Marco</creatorcontrib><creatorcontrib>Morales, César</creatorcontrib><creatorcontrib>Mella, Jaime</creatorcontrib><title>Arylamines QSAR-Based Design and Molecular Dynamics of New Phenylthiophene and Benzimidazole Derivatives with Affinity for the C111, Y268, and H73 Sites of SARS-CoV-2 PLpro Enzyme</title><title>Pharmaceuticals (Basel, Switzerland)</title><addtitle>Pharmaceuticals (Basel)</addtitle><description>A non-structural SARS-CoV-2 protein, PLpro, is involved in post-translational modifications in cells, allowing the evasion of antiviral immune response mechanisms. In this study, potential PLpro inhibitory drugs were designed using QSAR, molecular docking, and molecular dynamics. A combined QSAR equation with physicochemical and Free-Wilson descriptors was formulated. The r
, q
, and r
values were 0.833, 0.770, and 0.721, respectively. From the equation, it was found that the presence of an aromatic ring and a basic nitrogen atom is crucial for obtaining good antiviral activity. Then, a series of structures for the binding sites of C111, Y268, and H73 of PLpro were created. The best compounds were found to exhibit pIC
values of 9.124 and docking scoring values of -14 kcal/mol. The stability of the compounds in the cavities was confirmed by molecular dynamics studies. A high number of stable contacts and good interactions over time were exhibited by the aryl-thiophenes Pred14 and Pred15, making them potential antiviral candidates.</description><subject>Amino acids</subject><subject>Analysis</subject><subject>Antiviral agents</subject><subject>Antiviral drugs</subject><subject>Atazanavir</subject><subject>Benzimidazoles</subject><subject>Chemical properties</subject><subject>coronavirus</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Drugs</subject><subject>Enzyme kinetics</subject><subject>Enzymes</subject><subject>Etravirine</subject><subject>Free-Wilson</subject><subject>Health aspects</subject><subject>Hydrogen bonds</subject><subject>Molecular dynamics</subject><subject>Mortality</subject><subject>Mutation</subject><subject>PLpro</subject><subject>Proteins</subject><subject>QSAR</subject><subject>RNA</subject><subject>RNA polymerase</subject><subject>SARS-CoV-2</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Structure</subject><subject>Structure-activity relationship (Pharmacology)</subject><subject>Structure-activity relationships</subject><subject>Testing</subject><subject>Thiophene</subject><subject>Vaccines</subject><issn>1424-8247</issn><issn>1424-8247</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptks9uEzEQxlcIREvhwgMgS1wQ6hZ77bW9xzT9KwUoBJA4rRzvOHG0awd702rzWrwgblJaQMgHj0a_75sZzWTZS4KPKK3wu9WCCFxijvmjbJ-wguWyYOLxH_Fe9izGJcalIIw8zfaoFBUjQuxnP0dhaFVnHUT0aTr6nB-rCA06gWjnDinXoPe-Bb1uVUAng0ukjsgb9AFu0NUC3ND2C-tXKYItfQxuYzvbqE2SJZtgr1Vvr5P7je0XaGSMdbYfkPEB9QtAY0LIIfpecHm41V8Iiqa2h22R1M80H_tveYGuJqvg0anbDB08z54Y1UZ4cfcfZF_PTr-ML_LJx_PL8WiSayZZnwsNeEYlrzSRqmK6bLAQRhYzOqNlpU3TFIXWxOAZazATTEgwElIn2NCKS0IPssudb-PVsl4F26kw1F7ZepvwYV6r0FvdQl1xTigQY3hBmZSywkQoLHTJOTSmYMnrzc4rjfFjDbGvOxs1tK1y4Nexpml9VJKC8IS-_gdd-nVwadJElRUvGeHlAzVXqb51xvdB6VvTeiSqkpWYUJqoo_9Q6TWQNukdGJvyfwne7gQ6-BgDmPu5Ca5vr61-uLYEv7rrdD3roLlHf58X_QWuN8o9</recordid><startdate>20240501</startdate><enddate>20240501</enddate><creator>Sabadini, Gianfranco</creator><creator>Mellado, Marco</creator><creator>Morales, César</creator><creator>Mella, Jaime</creator><general>MDPI AG</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7XB</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-2434-8461</orcidid><orcidid>https://orcid.org/0000-0001-9577-5180</orcidid><orcidid>https://orcid.org/0009-0009-1925-3167</orcidid></search><sort><creationdate>20240501</creationdate><title>Arylamines QSAR-Based Design and Molecular Dynamics of New Phenylthiophene and Benzimidazole Derivatives with Affinity for the C111, Y268, and H73 Sites of SARS-CoV-2 PLpro Enzyme</title><author>Sabadini, Gianfranco ; Mellado, Marco ; Morales, César ; Mella, Jaime</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c484t-7ce0b3869c18a94c5d077f82b3b359cfdd22cc1f0b4d047478ef8e2680f396813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Amino acids</topic><topic>Analysis</topic><topic>Antiviral agents</topic><topic>Antiviral drugs</topic><topic>Atazanavir</topic><topic>Benzimidazoles</topic><topic>Chemical properties</topic><topic>coronavirus</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Drugs</topic><topic>Enzyme kinetics</topic><topic>Enzymes</topic><topic>Etravirine</topic><topic>Free-Wilson</topic><topic>Health aspects</topic><topic>Hydrogen bonds</topic><topic>Molecular dynamics</topic><topic>Mortality</topic><topic>Mutation</topic><topic>PLpro</topic><topic>Proteins</topic><topic>QSAR</topic><topic>RNA</topic><topic>RNA polymerase</topic><topic>SARS-CoV-2</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Structure</topic><topic>Structure-activity relationship (Pharmacology)</topic><topic>Structure-activity relationships</topic><topic>Testing</topic><topic>Thiophene</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sabadini, Gianfranco</creatorcontrib><creatorcontrib>Mellado, Marco</creatorcontrib><creatorcontrib>Morales, César</creatorcontrib><creatorcontrib>Mella, Jaime</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest - Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Pharmaceuticals (Basel, Switzerland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sabadini, Gianfranco</au><au>Mellado, Marco</au><au>Morales, César</au><au>Mella, Jaime</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Arylamines QSAR-Based Design and Molecular Dynamics of New Phenylthiophene and Benzimidazole Derivatives with Affinity for the C111, Y268, and H73 Sites of SARS-CoV-2 PLpro Enzyme</atitle><jtitle>Pharmaceuticals (Basel, Switzerland)</jtitle><addtitle>Pharmaceuticals (Basel)</addtitle><date>2024-05-01</date><risdate>2024</risdate><volume>17</volume><issue>5</issue><spage>606</spage><pages>606-</pages><issn>1424-8247</issn><eissn>1424-8247</eissn><abstract>A non-structural SARS-CoV-2 protein, PLpro, is involved in post-translational modifications in cells, allowing the evasion of antiviral immune response mechanisms. In this study, potential PLpro inhibitory drugs were designed using QSAR, molecular docking, and molecular dynamics. A combined QSAR equation with physicochemical and Free-Wilson descriptors was formulated. The r
, q
, and r
values were 0.833, 0.770, and 0.721, respectively. From the equation, it was found that the presence of an aromatic ring and a basic nitrogen atom is crucial for obtaining good antiviral activity. Then, a series of structures for the binding sites of C111, Y268, and H73 of PLpro were created. The best compounds were found to exhibit pIC
values of 9.124 and docking scoring values of -14 kcal/mol. The stability of the compounds in the cavities was confirmed by molecular dynamics studies. A high number of stable contacts and good interactions over time were exhibited by the aryl-thiophenes Pred14 and Pred15, making them potential antiviral candidates.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>38794177</pmid><doi>10.3390/ph17050606</doi><orcidid>https://orcid.org/0000-0002-2434-8461</orcidid><orcidid>https://orcid.org/0000-0001-9577-5180</orcidid><orcidid>https://orcid.org/0009-0009-1925-3167</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1424-8247 |
ispartof | Pharmaceuticals (Basel, Switzerland), 2024-05, Vol.17 (5), p.606 |
issn | 1424-8247 1424-8247 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_96613e1ff62348889017a07c566edf24 |
source | PubMed Central(OA); ProQuest - Publicly Available Content Database; Coronavirus Research Database |
subjects | Amino acids Analysis Antiviral agents Antiviral drugs Atazanavir Benzimidazoles Chemical properties coronavirus Coronaviruses COVID-19 Drugs Enzyme kinetics Enzymes Etravirine Free-Wilson Health aspects Hydrogen bonds Molecular dynamics Mortality Mutation PLpro Proteins QSAR RNA RNA polymerase SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Structure Structure-activity relationship (Pharmacology) Structure-activity relationships Testing Thiophene Vaccines |
title | Arylamines QSAR-Based Design and Molecular Dynamics of New Phenylthiophene and Benzimidazole Derivatives with Affinity for the C111, Y268, and H73 Sites of SARS-CoV-2 PLpro Enzyme |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T12%3A04%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Arylamines%20QSAR-Based%20Design%20and%20Molecular%20Dynamics%20of%20New%20Phenylthiophene%20and%20Benzimidazole%20Derivatives%20with%20Affinity%20for%20the%20C111,%20Y268,%20and%20H73%20Sites%20of%20SARS-CoV-2%20PLpro%20Enzyme&rft.jtitle=Pharmaceuticals%20(Basel,%20Switzerland)&rft.au=Sabadini,%20Gianfranco&rft.date=2024-05-01&rft.volume=17&rft.issue=5&rft.spage=606&rft.pages=606-&rft.issn=1424-8247&rft.eissn=1424-8247&rft_id=info:doi/10.3390/ph17050606&rft_dat=%3Cgale_doaj_%3EA795450133%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c484t-7ce0b3869c18a94c5d077f82b3b359cfdd22cc1f0b4d047478ef8e2680f396813%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3059654165&rft_id=info:pmid/38794177&rft_galeid=A795450133&rfr_iscdi=true |